Selective expansion of CD16highCCR2- subpopulation of circulating monocytes with preferential production of haem oxygenase (HO)-1 in response to acute inflammation.
Monocytes are composed of two distinct subpopulations in the peripheral blood as determined by their surface antigen expressions, profiles of cytokine production and functional roles played in vivo. We attempted to delineate the unique functional roles played by a minor CD16(high)CCR2(-) subpopulation of circulating monocytes. They produced significant levels of interleukin (IL)-6 and tumour necrosis factor (TNF)-alpha, but very low levels of IL-10 upon in vitro stimulation. Characteristic profiles of cytokine production were confirmed by stimulating purified subpopulations of monocytes after cell sorting. It was noteworthy that freshly isolated CD16(high)CCR2(-) monocyte subpopulations produced significant levels of haem oxygenase (HO)-1, whereas the major CD16(low)CCR2(+) subpopulation produced little. These results were contrary to the generally accepted notion that the CD16(high)CCR2(-) monocyte subpopulation plays a predominantly proinflammatory role in vivo. The CD16(high)CCR2(-) subpopulation increased in Kawasaki disease and influenza virus infection. In accord with this, HO-1 mRNA expression by mononuclear cells was significantly increased in these illnesses. These results indicate that CD16(high)CCR2(-) subpopulations are of a distinct lineage from CD16(low)CCR2(+) monocytes. More importantly, they may represent a monocyte subpopulation with a unique functional role to regulate inflammation by producing HO-1 in steady state in vivo.
Mizuno
K
K
Department of Pediatrics, Angiogenesis and Vascular Development, Graduate School of Medicine, Faculty of Medicine, Kanazawa University, Kanazawa, Japan.
Toma
T
T
Tsukiji
H
H
Okamoto
H
H
Yamazaki
H
H
Ohta
K
K
Ohta
K
K
Kasahara
Y
Y
Koizumi
S
S
Yachie
A
A
D000208:Acute Disease; D002478:Cells, Cultured; D018932:Chemokine CCL2 / Q000276:immunology; D051547:Heme Oxygenase-1 / Q000096:biosynthesis / Q000276:immunology*; D006801:Humans; D007251:Influenza, Human / Q000276:immunology; D016753:Interleukin-10 / Q000276:immunology; D015850:Interleukin-6 / Q000276:immunology; D018950:Lipopolysaccharide Receptors / Q000276:immunology; D008565:Membrane Proteins / Q000096:biosynthesis / Q000276:immunology*; D009000:Monocytes / Q000276:immunology*; D009080:Mucocutaneous Lymph Node Syndrome / Q000276:immunology; D012333:RNA, Messenger / Q000032:analysis; D054390:Receptors, CCR2; D019707:Receptors, Chemokine / Q000276:immunology*; D017452:Receptors, IgG / Q000276:immunology*; D051193:Toll-Like Receptors / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
C515334:CCR2 protein, human; D018932:Chemokine CCL2; D015850:Interleukin-6; D018950:Lipopolysaccharide Receptors; D008565:Membrane Proteins; D012333:RNA, Messenger; D054390:Receptors, CCR2; D019707:Receptors, Chemokine; D017452:Receptors, IgG; D051193:Toll-Like Receptors; D014409:Tumor Necrosis Factor-alpha; D016753:Interleukin-10; C496541:HMOX1 protein, human; D051547:Heme Oxygenase-1